Where's the utility in Bayesian data-monitoring of clinical trials? Comment

被引：0
|
作者：
Carlin, B [1 ]
机构：
[1] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN 55455 USA
来源：
CLINICAL TRIALS | 2005年 / 2卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：205 / 206
页数：2
相关论文
共 50 条
  • [41] COMPARISON OF BAYESIAN WITH GROUP SEQUENTIAL-METHODS FOR MONITORING CLINICAL-TRIALS
    FREEDMAN, LS
    SPIEGELHALTER, DJ
    CONTROLLED CLINICAL TRIALS, 1989, 10 (04): : 357 - 367
  • [42] A BAYESIAN-APPROACH TO THE ANALYSIS OF DATA FROM CLINICAL-TRIALS
    NOVICK, MR
    GRIZZLE, JE
    JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1965, 60 (309) : 81 - 96
  • [43] Bayesian sample size for exploratory clinical trials incorporating historical data
    Whitehead, John
    Valdes-Marquez, Elsa
    Johnson, Patrick
    Graham, Gordon
    STATISTICS IN MEDICINE, 2008, 27 (13) : 2307 - 2327
  • [44] Bayesian predictive monitoring with bivariate binary outcomes in phase II clinical trials
    Sambucini, Valeria
    COMPUTATIONAL STATISTICS & DATA ANALYSIS, 2019, 132 : 18 - 30
  • [45] Some extensions and applications of a Bayesian strategy for monitoring multiple outcomes in clinical trials
    Thall, PF
    Sung, HG
    STATISTICS IN MEDICINE, 1998, 17 (14) : 1563 - 1580
  • [46] Clinical utility of therapeutic drug monitoring of mycophenolic acid in transplantation medicine: Where are we?
    Shipkova, Maria
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2009, 33 (02): : 88 - 98
  • [47] Bayesian Safety and Futility Monitoring in Phase II Trials Using One Utility-Based Rule
    Lee, Juhee
    Thall, Peter F.
    STATISTICS IN MEDICINE, 2024, 43 (29) : 5583 - 5595
  • [48] DATA MONITORING IN CLINICAL-TRIALS - THE CASE FOR STOCHASTIC CURTAILMENT
    DAVIS, BR
    HARDY, RJ
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (09) : 1033 - 1042
  • [49] Principles and procedures for data and safety monitoring in pragmatic clinical trials
    Gregory E. Simon
    Susan M. Shortreed
    Rebecca C. Rossom
    Robert B. Penfold
    Jo Ann M. Sperl-Hillen
    Patrick O’Connor
    Trials, 20
  • [50] Monitoring clinical trials - interim data should be publicly available
    Lilford, RJ
    Braunholtz, D
    Edwards, S
    Stevens, A
    BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7310): : 441 - 442
12345